1. Newly listed items on February 1, 2018
|
product code |
Product Name |
Ingredient content |
drug price |
Remarks |
|
648104020 |
Hebicom Cap. |
biphenyl dimethyl dicarboxylate 12.5mg ursodeoxycholic acid 50mg |
260 won/capsule |
Salary recognized from February 1, 2018 |
2. Items whose actual drug prices were reduced on February 1, 2018
|
product code |
Product Name |
upper limit amount |
To be adjusted price |
cut amount |
reduction rate |
|
648101520 |
Ecrovar tablet (aciclovir)_(0.2g/1 tablet) |
449 |
448 |
1 |
-0.2% |
|
648101530 |
Ecrovar tablets 400 mg (Acyclovir)_(0.4g/1 tablet) |
496 |
490 |
6 |
-1.2% |
|
648101541 |
Ecrovage (acyclovir) (Export name: Sevirin Injection, Biruhexal Injection)_(0.25g/1 bottle) |
8,025 |
7,463 |
562 |
-7.0% |
|
648101561 |
Ecroba Cream (Acyclovir)_(0.25g/5g) |
3,015 |
3,011 |
4 |
-0.1% |
□ Ministry of Health and Welfare Notice No. 2018-10
Article 22 (1) of the Enforcement Decree of the National Health Insurance Act and “Standards for National Health Insurance Nursing Care Benefits”
The “Pharmaceutical Benefit List and Benefit Maximum Amount Table” pursuant to Article 8, Paragraph 2 of the “Rules” has been revised and announced.